 Organovo NASDAQ:ONVO and Fate Therapeutics NASDAQ:FATE are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, institutional ownership, risk and valuation. Insider and Institutional Ownership 48.7 of Organovo shares are held by institutional investors. Comparatively, 95.2 of ... 